Latest Headlines
-
SGS Introduces New Specialized Bioanalytical Testing Services In North America
8/21/2024
SGS, the world’s leading testing, inspection and certification company, announces the introduction of new specialized bioanalytical testing services in the North American pharmaceutical and biopharmaceutical markets.
-
Thermo Scientific VisionMate HSX High Speed Barcode Reader Integrates With Elabnext For Seamless Sample Tracking
8/21/2024
eLabNext, an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic Lab Notebook (ELN), announced today that its platform is now able to integrate with the Thermo Scientific VisionMate HSX High Speed Barcode Reader.
-
ACCU Reference Medical Lab Revolutionizes Tick-Borne Disease Diagnostics With New Molecular PCR Panels
8/20/2024
ACCU Reference Medical Laboratory, a leading provider of advanced diagnostic services, is proud to announce the implementation and availability of our new molecular PCR (Polymerase Chain Reaction) panels for the diagnosis of tick-borne diseases.
-
Experts To Identify Essential Steps & Pitfalls To Help Clinical Laboratories Meet The Deadline To Comply With The FDA's Laboratory Developed Test (LDT) Rule
8/20/2024
With the first important deadline for compliance with the Food and Drug Administration’s (FDA) LDT rule only eight months away, experts urge clinical laboratories performing LDTs to take immediate action.
-
Association For Molecular Pathology Files Lawsuit Against FDA To Challenge Final Rule On Regulation For Laboratory Developed Testing Procedures
8/20/2024
The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, and world-renowned pathologist Michael Laposata, MD, PhD, today announced the filing of a lawsuit challenging the recent U.S. Food and Drug Administration (FDA) Rule that regulates laboratory developed test (LDT) procedures as medical devices under the Federal Food, Drug, and Cosmetic Act.
-
Panomiq Set's New Benchmark With 100% Accuracy In Whole Genome Sequencing Testing
8/20/2024
BioAro, a leading precision health and genomics company, is proud to announce a groundbreaking achievement in the field of Whole Genome Sequencing (WGS).
-
SCG Cell Therapy And A*Star Launch Joint Labs With Collaboration Nearing S$30M To Advance iPSC Technology Towards Scalable GMP Manufacturing Of Cellular Immunotherapies
8/16/2024
SCG Cell Therapy (SCG) and the Agency for Science, Technology and Research (A*STAR) announced the launch joint laboratories for cellular immunotherapies. This collaboration, at a combined funding of close to S$30 million supported under Singapore's Research, Innovation and Enterprise 2025 Plan (RIE2025), aims to advance the development of induced pluripotent stem cell (iPSC) technology to produce novel cell therapies that meet Good Manufacturing Practice (GMP) standards.
-
Questhealth.Com Introduces 13 New Blood Tests To Identify Micronutrient Deficiencies
8/15/2024
Micronutrients are essential vitamins and minerals that are vital for well-being and disease prevention, but deficiencies can commonly be caused by food allergies and dietary restrictions, certain prescription medications, or chronic health conditions. At least one in three Americans are at risk of nutrient deficiencies1.
-
Alpenglow Biosciences And Partners Secure A Total Of $24M For Development Of Alpenglow's 3D Spatial Pathology Platform
8/15/2024
Alpenglow Biosciences, a leading 3D spatial biology company, was recently awarded contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH) and secured additional investment to further its clinical product development.
-
KUBTEC and SAKURA FINETEK USA Announce Strategic Partnership To Improve Histopathology Laboratory Grossing Efficiency
8/15/2024
KUBTEC, a global leader in pathology specimen imaging technology, and Sakura Finetek USA, a global leader in histopathology laboratory solutions, are excited to announce a new strategic partnership.